AbbVie (ABBV) Plans $7.5B Tender Offer

With earnings, AbbVie (NYSE: ABBV) said it plans to commence a tender offer to purchase for cash up to $7.5 billion in value of shares of its common stock through a modified "Dutch auction" tender offer at a specified price range to be determined. AbbVie expects to commence the tender offer as early as May 1, 2018.

The tender offer forms a part of AbbVie's $10 billion stock repurchase program announced on February 15, 2018.

You May Also Be Interested In

• A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity
• RBC Capital Upgrades GEA Group AG (G1A:GR) (GEAGY) to Outperform
• Bending Spoons closes IPO, raises ~$954M on Nasdaq